A cross-reacting material CRM197 conjugate vaccine induces diphtheria toxin neutralizing antibody response in children and adolescents infected or not with HIV - Silva, Giselle P.; Santos, Rafaela S.; Pereira-Manfro, Wânia F.; Ferreira, Bianca; Barreto, Daniella M.; Frota, Ana Cristina C.; Hofer, Cristina B.; Milagres, Lucimar G. (Vaccine, 2017)
Keywords: adolescents; Allergy and Immunology; Bactericidal antibody; children; Conjugate vaccine; CRM197; Diphtheria neutralizing antibody; herd immunity; Human immunodeficiency virus; neutralization; neutralizing antibodies; patients; serotypes; vaccination; vaccines; HI; DTP; Conjugate vaccine; MenC; CRM197; DT-Nab; MTT; Bactericidal antibody; SBA; Diphtheria neutralizing antibody; HC; V1; V2; V3; V4; HAART; before immunization; brometo de [3-(4,5-dimetiltiazol-2yl)-2,5-difenil tetrazolium]; one-two months after first dose; serum bactericidal antibody; CRM 197; one year after first dose; highly active antiretroviral therapy; healthy controls; diphtheria-tetanus-pertussis; cross-reacting material; one-two months after booster; diphtheria toxin neutralizing antibody; HIV-infected children/adolescents; serogroup C meningococcus